The first authorised treatment for epidermolysis bullosa in Ireland has been made available, marking a major milestone for patients living with the painful rare skin condition.
Cutaneous Squamous Cell Carcinoma in Ireland: Rising Incidence, Evolving Treatments, and the Need for Proactive Prevention Introduction Skin cancer is the most common cancer in Ireland with over…
World Psoriasis Day is celebrated annually on 29th October across the world. In the UK, Psoriasis Awareness Week, also runs at the end of October and incorporates World…
Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition. Disease severity is classified and assessed by clinicians using the Hurley Staging system from I- III. This ranges from…
Atopic dermatitis (AD), also known as eczema, is the most common skin condition in children, affecting 30% of Irish babies in the first 2 years of life. AD…
Skin cancer in Ireland Skin cancer is the most common cancer in Ireland. More than 11,000 cases are diagnosed annually accounting for over one-third of all cancers diagnosed,…
Written by Claire Doyle, Dermatology Department, Tallaght Hospital Merkel Cell Carcinoma (MCC) is a rare aggressive neuroendocrine cutaneous malignancy most commonly observed in those over 65 years of…
The Irish Melanoma Forum 12th Annual Scientific Meeting took place this month on Thursday 2nd May. Hospital Professional News recently spoke to Professor Shirley Potter and Professor Des…
Introduction: Psoriasis is a chronic multisystem autoimmune disease with cutaneous involvement. It is characterised by the rapid growth of skin cells, leading to the formation of thick, red,…
Patient initiated follow up (PIFU) is an alternative approach to a traditional, fixed appointment-based system that offers a flexible review for patients when needed. It has successfully been…
You’re all caught up.
